Skip to main content

Advertisement

SpringerLink
Log in

Targeting the IL-17–TH17 pathway

  • From the Analyst's Couch
  • Published:

From Nature Reviews Drug Discovery

View current issue Sign up to alerts

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Figure 1: Targeting the IL-17–TH17 pathway.

References

  1. Miossec, P. & Kolls, J. K. Targeting IL-17 and TH17 cells in chronic inflammation. Nature Rev. Drug Discov. 11, 763–776 (2012).

    Article  CAS  Google Scholar 

  2. Levin, E. C. et al. Biologic fatigue in psoriasis. J. Dermatolog Treat. 1, 78–82 (2014).

    Article  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Trinity Partners at 675 Third Avenue, 20th Floor, New York, New York 10017, USA.,

    Hilary S. Bartlett & Ryan P. Million

Authors
  1. Hilary S. Bartlett
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Ryan P. Million
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding authors

Correspondence to Hilary S. Bartlett or Ryan P. Million.

Ethics declarations

Competing interests

The authors declare no competing financial interests.

PowerPoint slides

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Bartlett, H., Million, R. Targeting the IL-17–TH17 pathway. Nat Rev Drug Discov 14, 11–12 (2015). https://doi.org/10.1038/nrd4518

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/nrd4518

  • Springer Nature Limited

This article is cited by

Search

Navigation